Digoxin use is associated with increased risk of stroke in patients with non-valvular atrial fibrillation - A nationwide population-based cohort study

International Journal of Cardiology

Volumn 169, Issue 2, 2013, Pages

  Chang, Shih Sheng ^a,b   Chang, Kuan Cheng ^a,b   Wang, Yu Chen ^a,b   Muo, Chih Hsin ^a   Pai, Pei Ying ^a,b   Chang, Chi Bin ^a   Li, Chi Yuan ^a   Sung, Fung Chang ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Atrial fibrillation; Digoxin; Platelet activation; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DIGOXIN; TICLOPIDINE;

ADULT; AGE DISTRIBUTION; AGED; ANTICOAGULANT THERAPY; ASIAN; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DRUG USE; FEMALE; FOLLOW UP; HAZARD RATIO; HEALTH INSURANCE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART FAILURE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; LETTER; MAJOR CLINICAL STUDY; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TAIWAN; TREATMENT OUTCOME;

ATRIAL FIBRILLATION; DIGOXIN; PLATELET ACTIVATION; STROKE;

AGED; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; COHORT STUDIES; DIGOXIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; RISK FACTORS; STROKE;

EID: 84887066562     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.08.103     Document Type: Article

References (10)

1. The Digitalis Investigation Group The effect of digoxin on mortality and morbidity in patients with heart failure N Engl J Med 336 1997 525 533
2. S.D. Corley, A.E. Epstein, and J.P. DiMarco Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study Circulation 109 2004 1509 1513
3. P. Hallberg, J. Lindback, B. Lindahl, U. Stenestrand, H. Melhus RIKS-HIA group Digoxin and mortality in atrial fibrillation: a prospective cohort study Eur J Clin Pharmacol 63 2007 959 971
4. J.A. Chirinos, A. Castrellon, and J.P. Zambrano Digoxin use is associated with increased platelet and endothelial cell activation in patients with nonvalvular atrial fibrillation Heart Rhythm 2 2005 525 529
5. W. Schoner, and G. Scheiner-Bobis Endogenous and exogenous cardiac glycosides and their mechanisms of action Am J Cardiovasc Drugs 7 2007 173 189
6. K. Gjesdal, J. Feyzi, and S.B. Olsson Digitalis: a dangerous drug in atrial fibrillation? An analysis of the SPORTIF III and V data Heart 94 2008 191 196
7. S.J. Connolly, A.J. Camm, and J.L. Halperin Dronedarone in high-risk permanent atrial fibrillation N Engl J Med 365 2011 2268 2276
8. S.H. Hohnloser, H.J.G.M. Crijns, and M. van Eickels Effect of dronedarone on cardiovascular events in atrial fibrillation N Engl J Med 360 2009 668 678
9. G. Davi, and C. Patrono Platelet activation and atherothrombosis N Engl J Med 357 2007 2482 2494
10. G. Pongratz, M. Brandt-Pohlmann, and K.H. Henneke Platelet activation in embolic and preembolic status of patients with nonrheumatic atrial fibrillation Chest 111 1997 929 933